Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
mesenchymal stem cells
- Development stage
- Phase 4
- Lead developer
- Cell Energy Life Sciences Group
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Mesenchymal stem cells (MSCs) from Cell Energy Life Sciences Group are an investigational cell therapy being developed for the treatment of lung injury caused by major infectious diseases, including viral pneumonia and potentially COVID-19. These multipotent cells are administered via intravenous infusion and are designed to home to damaged lung tissue. Once localized, they exert therapeutic effects by secreting a variety of paracrine factors, such as cytokines and growth factors, which modulate the host's immune response. This action helps to suppress the systemic inflammatory response (cytokine storm), reduce alveolar-capillary membrane permeability, and promote the regeneration of lung tissue, thereby improving respiratory function in patients with acute lung injury or ARDS.
- Other names
- MSCsMesenchymal stromal cellsStem cellsCell Energy MSCs
Beyond the preview
Go deeper on mesenchymal stem cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on mesenchymal stem cells.